EDITORIAL
Accepted on 04 Mar 2025
Editorial: The Next Stage of Therapeutic Design-Selective Targeting of Multi-Antigen Profiles
doi 10.3389/fimmu.2025.1585904
- Frontiers in Immunology
- Cancer Immunity and Immunotherapy
- Research Topics
- The Next Stage of Immune Cell Design: Selective Targeting of Multi-Antigen Profiles
The Next Stage of Immune Cell Design: Selective Targeting of Multi-Antigen Profiles
3,307
Total downloads
12k
Total views and downloads
Articles
ORIGINAL RESEARCH
Accepted on 21 Feb 2025
Multi-targeted, NOT gated CAR-T cells as a strategy to protect normal lineages for blood cancer therapy
doi 10.3389/fimmu.2025.1493329
- 309 views
PERSPECTIVE
Published on 10 Feb 2025
Six events that shaped antibody approvals in oncology
doi 10.3389/fimmu.2025.1533796
- 733 views
ORIGINAL RESEARCH
Published on 13 Dec 2024
In vivo programmed myeloid cells expressing novel chimeric antigen receptors show potent anti-tumor activity in preclinical solid tumor models
doi 10.3389/fimmu.2024.1501365
- 1,917 views
REVIEW
Published on 13 Nov 2024
Logic-gated and contextual control of immunotherapy for solid tumors: contrasting multi-specific T cell engagers and CAR-T cell therapies
doi 10.3389/fimmu.2024.1490911
- 2,913 views
PERSPECTIVE
Published on 07 Nov 2024
Identifying optimal tumor-associated antigen combinations with single-cell genomics to enable multi-targeting therapies
doi 10.3389/fimmu.2024.1492782
- 1,551 views
- 1 citation
ORIGINAL RESEARCH
Published on 19 Jul 2024
iPSC-derived NK cells expressing high-affinity IgG Fc receptor fusion CD64/16A to mediate flexible, multi-tumor antigen targeting for lymphoma
doi 10.3389/fimmu.2024.1407567
- 1,753 views
Published in
Frontiers in Immunology
Cancer Immunity and Immunotherapy
T Cell Biology
NK and Innate Lymphoid Cell Biology
Participating Journals
Frontiers in Oncology
- 3.5 impact factor
- 6.2 citescore